Ritlecitinib is the only approved treatment for adolescents right now, he adds
2026 Forbes Best-in-State Wealth Management Teams: Awarded January 2026
On the same date, Julian Gill also requested case numbers for all adverse events in the FAERS system related to tirzepatide and semaglutide products produced by Empower Pharmacy in Houston, Texas (both the 503A and 503B products). Noa Metta submitted on September 24 a request for FDA Form 483 inspection reports, warning letters, Establishment Inspection Reports, and adverse event reports relating to pharmacies conducting unauthorized compounding practices, involving semaglutide, tirzepatide, or similar drugs, between January 1, 2022, and the present. Several additional requests addressed non-compounding issues related to GLP-1 drugs, two mentioning Eli Lilly and one mentioning Ozempic and Wegovy
Body Balance Medical is a LegitScript-certified clinic with a physical Las Vegas location serving Las Vegas, Summerlin, Henderson, and surrounding areas
